-
Loading metrics
Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma
- Nicholas Brown,
- Catherine McBain,
- Stephen Nash,
- Kirsten Hopkins,
- Paul Sanghera,
- Frank Saran,
- Mark Phillips,
- Fiona Dungey,
- Laura Clifton-Hadley,
- Katharina Wanek
x
- Published: May 27, 2016
- https://doi.org/10.1371/journal.pone.0156369